Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07429851
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed diagnosis of well-differentiated high grade neuroendocrine tumor (Ki-67 \> 20% according to WHO 2022) performed or reviewed by a NEN-dedicated pathologist.
* Primary tumor site:thyme, lung and duodenum-pancreas NETs.
* Advanced stage of tumor disease and Any number of lines of therapy
* Sufficient available clinical data on diagnosis, treatments, outcomes.
Exclusion Criteria:
* Poorly differentiated neuroendocrine carcinomas (NECs), GEP NET G1/G2, pulmonary carcinoid with Ki-67 \< 20%.
* Diagnosis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs)
* Inadequate or unavailable tumor tissue for molecular analysis.
* Incomplete clinical records or follow-up.
* Other primary sites, except lung or pancreas.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07429851
Study Brief:
Protocol Section:
NCT07429851